BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17471546)

  • 1. Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients.
    Cohen P; Pagnoux C; Mahr A; Arène JP; Mouthon L; Le Guern V; André MH; Gayraud M; Jayne D; Blöckmans D; Cordier JF; Guillevin L;
    Arthritis Rheum; 2007 May; 57(4):686-93. PubMed ID: 17471546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
    Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
    Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.
    Guillevin L; Cohen P; Mahr A; Arène JP; Mouthon L; Puéchal X; Pertuiset E; Gilson B; Hamidou M; Lanoux P; Bruet A; Ruivard M; Vanhille P; Cordier JF
    Arthritis Rheum; 2003 Feb; 49(1):93-100. PubMed ID: 12579599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.
    Guillevin L; Lhote F; Cohen P; Jarrousse B; Lortholary O; Généreau T; Léon A; Bussel A
    Arthritis Rheum; 1995 Nov; 38(11):1638-45. PubMed ID: 7488285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials.
    Samson M; Puéchal X; Devilliers H; Ribi C; Cohen P; Stern M; Pagnoux C; Mouthon L; Guillevin L;
    J Autoimmun; 2013 Jun; 43():60-9. PubMed ID: 23590801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides.
    Gayraud M; Guillevin L; Cohen P; Lhote F; Cacoub P; Deblois P; Godeau B; Ruel M; Vidal E; Piontud M; Ducroix JP; Lassoued S; Christoforov B; Babinet P
    Br J Rheumatol; 1997 Dec; 36(12):1290-7. PubMed ID: 9448590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: indications of plasma exchanges.
    Guillevin L; Lhote F
    Transfus Sci; 1994 Dec; 15(4):371-88. PubMed ID: 10155556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.
    Samson M; Puéchal X; Mouthon L; Devilliers H; Cohen P; Bienvenu B; Ly KH; Bruet A; Gilson B; Ruivard M; Pertuiset E; Hamidou M; Pagnoux C; Terrier B; Guillevin L;
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):176-184. PubMed ID: 28422001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A meta-analysis of 3 prospective controlled trials including 182 patients over 12 years.
    Guillevin L; Lhote F; Jarrousse B; Fain O
    Ann Med Interne (Paris); 1992; 143(6):405-16. PubMed ID: 1363508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.
    Guillevin L; Fain O; Lhote F; Jarrousse B; Le Thi Huong D; Bussel A; Leon A
    Arthritis Rheum; 1992 Feb; 35(2):208-15. PubMed ID: 1346499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.
    Guillevin L; Lhote F; Gayraud M; Cohen P; Jarrousse B; Lortholary O; Thibult N; Casassus P
    Medicine (Baltimore); 1996 Jan; 75(1):17-28. PubMed ID: 8569467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.
    Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B;
    Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients.
    Généreau T; Lortholary O; Leclerq P; Grenet D; Tubéry M; Sicard D; Caubarrère I; Guillevin L
    Br J Rheumatol; 1994 Oct; 33(10):959-62. PubMed ID: 7921758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Churg-Strauss syndrome revealed by granulomatous acute pericarditis: two case reports and a review of the literature.
    Agard C; Rendu E; Leguern V; Ponge T; Masseau A; Barrier JH; Trochu JN; Hamidou MA; Guillevin L
    Semin Arthritis Rheum; 2007 Jun; 36(6):386-91. PubMed ID: 17303217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterior ischaemic optic neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature.
    Padovano I; Pazzola G; Pipitone N; Cimino L; Salvarani C
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S62-5. PubMed ID: 24144341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Churg-Strauss syndrome: clinical features and long-term follow-up of 16 patients].
    Lou J; Xu WB
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):524-8. PubMed ID: 19567070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Churg-Strauss syndrome and central retinal artery occlusion with good visual recovery.
    Kamata Y; Hashizume K; Kaneko M; Kurosaka D
    Indian J Ophthalmol; 2013 Apr; 61(4):178-9. PubMed ID: 23685491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha for maintenance of remission in Churg-Strauss syndrome: a long-term observational study.
    Metzler C; Csernok E; Gross WL; Hellmich B
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):24-30. PubMed ID: 20412698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.